New nanoparticle drug-delivery method may improve treatment for endometriosis
Researchers have engineered a drug treatment that shows rapid effectiveness against endometriosis in early testing, laying the foundation for a potential therapy for an incurable, chronic disease that affects 1 in 10 women. The targeted nanotherapy, developed by a team of scientists at Washington State University, reduced endometriosis symptoms and disease progression after a single dose in a…
Researchers at Washington State University have developed a new nanoparticle drug-delivery method that shows promising results in early testing for the treatment of endometriosis, a chronic and incurable condition affecting 1 in 10 women. The targeted nanotherapy, which reduced endometriosis symptoms and disease progression after a single dose in mice, employs niclosamide, a drug already approved for treating intestinal tapeworms, to specifically target disease-associated immune cells.
This novel approach overcomes the limitations of traditional treatments, which often come with undesirable side effects and short-term effectiveness. While the researchers are optimistic about the potential of this nanocarrier delivery system, the drug must still undergo rigorous testing in human trials to establish safety and efficacy.
Written by urgent.news from Phys.org's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
